NCT01404793View on ClinicalTrials.gov

SPME For Metabolomics And Concomitant Measurements Of Rocuronium Bromide Levels In Liver Transplantation

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2015

Conditions
Liver Failure
Interventions
DRUG

Rocuronium

After insertion of the new liver and restoration of portal venous flow, 0.6 mg kg-1 rocuronium will be administered

Trial Locations (1)

Unknown

Toronto General Hospital, Toronto

All Listed Sponsors
collaborator

University of Waterloo

OTHER

lead

University Health Network, Toronto

OTHER

NCT01404793 - SPME For Metabolomics And Concomitant Measurements Of Rocuronium Bromide Levels In Liver Transplantation | Biotech Hunter | Biotech Hunter